-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.
-
Summary
-
GeneDx Holdings Corp. annual/quarterly Deferred Income Tax Expense (Benefit) history and growth rate for Q2 2022.
- GeneDx Holdings Corp. Deferred Income Tax Expense (Benefit) for the quarter ending June 30, 2022 was -$48.6M.
- GeneDx Holdings Corp. annual Deferred Income Tax Expense (Benefit) for 2023 was -$1.09M, a 97.8% increase from 2022.
- GeneDx Holdings Corp. annual Deferred Income Tax Expense (Benefit) for 2022 was -$49.1M.
- GeneDx Holdings Corp. annual Deferred Income Tax Expense (Benefit) for 2021 was $0.000.
Deferred Income Tax Expense (Benefit), Quarterly (USD)